Neuronetics, Inc. logo

Neuronetics, Inc.

NASDAQ:STIM

Overview | Financials
Company Name Neuronetics, Inc.
Symbol STIM
Currency USD
Price 1.08
Market Cap 32,731,992
Dividend Yield 0%
52-week-range 0.664 - 5.07
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Keith J. Sullivan
Website https://www.neurostar.com

An error occurred while fetching data.

About Neuronetics, Inc.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System

Related Stocks

ImmuCell Corporation logo

ImmuCell Corporation

ICCC

3.53 USD

Mustang Bio, Inc. logo

Mustang Bio, Inc.

MBIO

0.248 USD

Silver Spike Investment Corp. logo

Silver Spike Investment Corp.

SSIC

10.735 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.79 USD

LifeMD, Inc. logo

LifeMD, Inc.

LFMD

5.13 USD

Curis, Inc. logo

Curis, Inc.

CRIS

4.35 USD

SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc.

SLS

1.16 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD